flamod
Biologicalexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2025 (NCT06681402)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Toll-like receptor 5AGONIST
TLR5 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06681402 | Phase 1 | Jan 31, 2025 | European Union, François Rabelais University, Institut National de la Santé Et de la Recherche Médicale, France |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Union | Government | 1 | 0 | 1 | 2025 |
| François Rabelais University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Institut National de la Santé Et de la Recherche Médicale, France | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1